Acro Biomedical Co (Acro Biomedical Co) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Acro Biomedical Co Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Acro Biomedical Co's net issuance of preferred for the three months ended in Jun. 2023 was $0.00 Mil. The number is 0, which means that Acro Biomedical Co has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Acro Biomedical Co's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Acro Biomedical Co Net Issuance of Preferred Stock Historical Data

The historical data trend for Acro Biomedical Co's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acro Biomedical Co Net Issuance of Preferred Stock Chart

Acro Biomedical Co Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Dec20

Dec21

Dec22

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Acro Biomedical Co Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Acro Biomedical Co Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Acro Biomedical Co Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Acro Biomedical Co's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Acro Biomedical Co (Acro Biomedical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Acro Biomedical Co Ltd (OTCPK:ACBM) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

12175 Visionary Way, Suite 1160, Fishers, IN, USA, 46038

Website

http://www.acrobiomedical.com

Acro Biomedical Co Ltd develops and manufactures nutritional products. The company offers cordyceps fungus for medicinal purposes. It also sells cordycepin and cordyceps powder.

Executives

Pao-chi Chu

director, 10 percent owner, officer: CEO

2F, NO. 356 SEC 1. DUNHUA S. RD., DA'AN DISTRICT, TAIPEI CITY F5 106

Acro Biomedical Co (Acro Biomedical Co) Headlines

No Headlines